- Tables of Contents (Vol. 53, No. 1~4, 2021)
-
- KMID: 2521596
- Cancer Res Treat.
- 2021 Oct;53(4):1213-1223.
-
- CITED
-
- Close
- SHARE
-
- Close
- Acknowledgment of Reviewers (2021)
-
- KMID: 2521597
- Cancer Res Treat.
- 2021 Oct;53(4):1224-1228.
-
- CITED
-
- Close
- SHARE
-
- Close
- The Law Changes Behaviors: Is It Just Enough?
-
Lee DH
- KMID: 2521565
- Cancer Res Treat.
- 2021 Oct;53(4):895-896.
- doi: 10.4143/crt.2021.1025
-
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea
-
Lee SU, Yang K, Moon SH, Suh YG, Yoo GS
- KMID: 2521570
- Cancer Res Treat.
- 2021 Oct;53(4):935-943.
- doi: 10.4143/crt.2021.409
Purpose Proton beam therapy (PBT) is a state-of-the-art technology employed in radiotherapy (RT) for cancer patients. This study characterized how PBT has been used in clinical practice in Korea. Materials and... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
-
Shi H, Zhang W, Bi X, Wang D, Xiao Z, Guan Y, Guan K, Tian J, Bai H, Hu L, Cao C, Jiang W, Hu Z, Zhang J, Chen Y, Zheng S, Feng X, Li C, Li Y, Ma J, Liu Y, Zhou A, Shou J
- KMID: 2521590
- Cancer Res Treat.
- 2021 Oct;53(4):1156-1165.
- doi: 10.4143/crt.2020.1356
Purpose Reduced quality of life after cystectomy has made bladder preservation a popular research topic for muscle-invasive bladder cancer (MIBC). Previous research has indicated significant tumor downstaging after neoadjuvant chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Impact of Capmatinib in the Treatment of Advanced Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification
-
Choi W, Park SY, Lee Y, Lim KY, Park M, Lee GK, Han JY
- KMID: 2521578
- Cancer Res Treat.
- 2021 Oct;53(4):1024-1032.
- doi: 10.4143/crt.2020.1331
Purpose Capmatinib, an oral MET kinase inhibitor, has demonstrated its efficacy against non–small cell lung cancer (NSCLC) with MET dysregulation. We investigated its clinical impact in advanced NSCLC with MET... -
- CITED
-
- Close
- SHARE
-
- Close
- Neurocognitive Effects of Chemotherapy for Colorectal Cancer: A Systematic Review and a Meta-Analysis of 11 Studies
-
Hwang SY, Kim K, Ha B, Lee D, Kim S, Ryu S, Yang J, Jung SJ
- KMID: 2521588
- Cancer Res Treat.
- 2021 Oct;53(4):1134-1147.
- doi: 10.4143/crt.2020.1191
Purpose Chemotherapy-related cognitive impairment (CRCI) is a controversial concept not much explored on colorectal cancer patients. Materials and Methods We identified 11 prospective studies: eight studies on 696 colorectal cancer patients who received... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database
-
Yu WS, Bae MK, Choi JK, Hong YK, Park IK
- KMID: 2521585
- Cancer Res Treat.
- 2021 Oct;53(4):1104-1112.
- doi: 10.4143/crt.2020.1213
Purpose The study aimed to investigate the current status and prognostic factors for overall survival in patients who had undergone pulmonary metastasectomy for colorectal cancer. Materials and Methods The data of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment
-
Lee HY, Kim HJ, Kwon JH, Baek SK, Won YW, Kim YJ, Baik SJ, Ryu H
- KMID: 2521566
- Cancer Res Treat.
- 2021 Oct;53(4):897-907.
- doi: 10.4143/crt.2021.327
Purpose The “Act on Hospice and Palliative Care and Decisions on Life-Sustaining Treatment for Patients at the End-of-Life” was enacted on February 3, 2016 and went into effect on February... -
- CITED
-
- Close
- SHARE
-
- Close
- Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
-
Wang HY, Deng L, Li YQ, Zhang X, Long YK, Zhang X, Feng YF, He Y, Tang T, Yang XH, Wang F
- KMID: 2521573
- Cancer Res Treat.
- 2021 Oct;53(4):973-982.
- doi: 10.4143/crt.2020.798
Purpose Current variability in methods for tumor mutational burden (TMB) estimation and reporting demonstrates the urgent need for a homogeneous TMB assessment approach. Here, we compared TMB distributions in different... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Acute Kidney Injury in Lung Cancer Patients
-
Cho S, Kang E, Kim JE, Kang U, Kang HG, Park M, Kim K, Kim DK, Joo KW, Kim YS, Yoon HJ, Lee H
- KMID: 2521577
- Cancer Res Treat.
- 2021 Oct;53(4):1015-1023.
- doi: 10.4143/crt.2020.1010
Purpose Acute kidney injury (AKI) in cancer patients is associated with increased morbidity and mortality. The incidence of AKI in lung cancer seems to be relatively higher compared with other solid... -
- CITED
-
- Close
- SHARE
-
- Close
- Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
-
Won YW, Kim HJ, Kwon JH, Lee HY, Baek SK, Kim YJ, Kim DY, Ryu H
- KMID: 2521567
- Cancer Res Treat.
- 2021 Oct;53(4):908-916.
- doi: 10.4143/crt.2021.325
Purpose In Korea, the “Act on Hospice and Palliative Care and Decisions on Life-sustaining Treatment for Patients at the End of Life” was enacted on February 4, 2018. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
-
Park C, Kim M, Kwak Y, Moon KC, Kim SH, Keam B, Kim YJ, Kim TM, Kim DW
- KMID: 2521594
- Cancer Res Treat.
- 2021 Oct;53(4):1195-1203.
- doi: 10.4143/crt.2020.1337
Purpose Angiosarcoma is a highly aggressive mesenchymal tumor. Although systemic chemotherapy is often considered for the inoperable or metastatic angiosarcoma, the outcome of such treatment is unsatisfactory and poorly delineated. Materials... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
-
Lee KH, Chie EK, Im SA, Kim JH, Kwon J, Han SW, Oh DY, Jang JY, Kim JS, Kim TY, Bang YJ, Kim SW, Ha SW
- KMID: 2521584
- Cancer Res Treat.
- 2021 Oct;53(4):1096-1103.
- doi: 10.4143/crt.2020.928
Purpose Despite curative resection, the 5-year survival for patients with resectable pancreatic cancer is less than 20%. Recurrence occurs both locally and at distant sites and effective multimodality adjuvant treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population
-
Kim HC, Ji W, Lee JC, Kim HR, Song SY, Choi CM, Korean Association for Lung Cancer, Korea Central Cancer Registry
- KMID: 2521579
- Cancer Res Treat.
- 2021 Oct;53(4):1033-1041.
- doi: 10.4143/crt.2020.1350
Purpose The optimal treatment for patients with stage III non-small cell lung cancer (NSCLC) remains controversial. This study aimed to investigate prognostic factors and clinical outcome in stage III NSCLC using... -
- CITED
-
- Close
- SHARE
-
- Close
- Fasting Blood Glucose, Cholesterol, and Risk of Primary Liver Cancer: The Kailuan Study
-
Ma X, Cui H, Sun M, Liu Q, Liu X, Li G, Wei Y, Fu Q, Liu S, Cao L
- KMID: 2521586
- Cancer Res Treat.
- 2021 Oct;53(4):1113-1122.
- doi: 10.4143/crt.2020.817
Purpose The influence of fasting blood glucose (FBG) and cholesterolemia primary liver cancer (PLC) in china was analyzed via a large prospective cohort study based on a community population, and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea
-
Kim HJ, Kim YJ, Kwon JH, Won YW, Lee HY, Baek SK, Ryu H, Kim DY
- KMID: 2521568
- Cancer Res Treat.
- 2021 Oct;53(4):917-925.
- doi: 10.4143/crt.2021.324
Purpose The main purpose of the Life-Sustaining Treatment Decisions Act recently enacted in Korea is to respect the patient’s self-determination. We aimed to investigate the current status and features of... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers
-
Jiang X, Jiang Y, Luo S, Sekar K, Koh CKT, Deivasigamani A, Dong Q, Zhang N, Li S, Hao F, Goh BKP, Ooi LL, Wang Y, Hui KM
- KMID: 2521571
- Cancer Res Treat.
- 2021 Oct;53(4):944-961.
- doi: 10.4143/crt.2020.466
Purpose NUF2 has been implicated in multiple cancers recently, suggesting NUF2 may play a role in the common tumorigenesis process. In this study, we aim to perform comprehensive meta-analysis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Preoperative Tumor Under-Staging on the Long-term Survival of Patients Undergoing Radical Gastrectomy for Gastric Cancer
-
Lin M, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Huang CM
- KMID: 2521587
- Cancer Res Treat.
- 2021 Oct;53(4):1123-1133.
- doi: 10.4143/crt.2020.651
Purpose This study aimed to evaluate the effect of preoperative tumor staging deviation (PTSD) on the long-term survival of patients undergoing radical gastrectomy for gastric cancer (RGGC). Materials and Methods Clinicopathological... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition
-
Li D, Tong Q, Lian Y, Chen Z, Zhu Y, Huang W, Wen Y, Wang Q, Liang S, Li M, Zheng J, Liu Z, Liu H, Guo L
- KMID: 2521580
- Cancer Res Treat.
- 2021 Oct;53(4):1042-1056.
- doi: 10.4143/crt.2020.1208
Purpose Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required.... -
- CITED
-
- Close
- SHARE
-
- Close
